KalGene Pharmaceuticals

Recent Finacing

Series A

Recent Raise

Undisclosed

KalGene is a pre-clinical biopharmaceutical company developing precision therapeutics for Alzheimer’s; lead program KAL‑ABP targets toxic amyloid‑beta oligomers, crosses the blood–brain barrier, and reduces plaques in models.